Company news
CollPlant Biotechnologies Ltd. news in 2021
CollPlant Biotechnologies Ltd.'s news releases, calls and decks from 2021, newest first.
CollPlant Announces Publication Highlighting its rhCollagen-based Photocurable Dermal Filler in the Plastic and Reconstructive Surgery Journal
December 1, 2021
CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results
November 17, 2021
CollPlant Announces Commercial Launch of BioInk Platform with Collink.3D™ for Use in 3D Bioprinting of Human Tissues, Scaffolds and Organs
November 14, 2021
CollPlant to Present at Dawson James Small Cap Growth Conference on October 21st
October 13, 2021
CollPlant's rhCollagen BioInk Used by Technion Researchers to Develop 3D Bioprinted Vascularized Tissue Constructs
October 10, 2021
CollPlant to Present at Fall Harvest - Best Ideas from the Buy-Side on October 5, 2021
September 29, 2021
CollPlant CEO Yehiel Tal to Discuss Emerging Uses of rhCollagen in Aesthetic and Regenerative Medicine at NANO.IL.2021 Conference
September 26, 2021
CollPlant CEO Yehiel Tal elected to the Board of Directors of the International Society for Biofabrication (ISBF)
September 8, 2021
CollPlant To Present at the H.C. Wainwright Annual Global Investment Conference in September
September 6, 2021
CollPlant Biotechnologies Provides Business Updates and Second Quarter 2021 Financial Results
August 18, 2021
CollPlant Appoints Medical Aesthetics Veteran Alisa Lask to Board of Directors
August 18, 2021
CollPlant Biotechnologies to Present on the Use of Collagen BioInk as a Platform for 3D Bioprinting of Tissues and Organs at the Biomaterials For 3D Printing Webinar
August 15, 2021
3D Systems and CollPlant Enter Co-development Agreement to Deliver Bioprinted Solutions for Improved Breast Reconstruction Treatments
June 21, 2021
CollPlant Announces Effectiveness of Uplisting to the Nasdaq Global Market®; Ordinary Shares Replace ADSs
June 3, 2021
CollPlant Biotechnologies Reports First Quarter 2021 Financial Results with Record Revenues of $14.5 Million
May 26, 2021
CollPlant Announces Uplisting to the Nasdaq Global Market® and Transition to Trading of Ordinary Shares Instead of ADSs
May 24, 2021
CollPlant Appoints Additive Manufacturing Executive, Hugh Evans to Its Board of Directors
March 28, 2021
CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2020
March 25, 2021
CollPlant To Present at the H.C. Wainwright Global Life Sciences Conference
March 3, 2021
Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung Transplants
February 24, 2021
CollPlant Announces Closing of $35.0 Million Registered Direct Offering of American Depositary Shares
February 17, 2021
CollPlant Announces $35.0 Million Registered Direct Offering of American Depositary Shares
February 10, 2021
CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft Tissue Filler Products
February 7, 2021
Decks in 2021
- H.C. Wainwright 23rd Annual Global Investment Conference 2021
Conference · 26 slides · Sep 13, 2021
- Investor Presentation (February 2021)
Investor deck · 27 slides · Feb 8, 2021